Surgicel® (Fibrillar) in Non-variceal UGI Bleeding

N/AUnknownNCT02054260

Soonchunhyang University Hospital

Overview

The aim of this study is to assess of effect of Surgicel® (Fibrillar) for preventing delayed bleeding after endoscopic hemostasis in non-variceal upper gastrointestinal bleeding

Study Type

INTERVENTIONAL

Conditions

Non-variceal Upper Gastrointestinal Bleeding

Interventions

SurgicelDRUG

Eligibility

Sex: ALLMin age: 20 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with non variceal upper gastrointestinal bleeding proven by esophagogastroduodenoscopy * Patients with active bleeding (Forrest classification Ia or Ib or IIa) Exclusion Criteria: * Patients with upper gastrointestinal tract malignancy * Patients with acute severe illness * Coagulopathy: liver cirrhosis, thrombocytopenia * Pregnant women

Locations (1)

Digestive Disease Center and Research Institute, Department of Internal Medicine, Soonchunhyang University College of Medicine

Bucheon-si, South Korea

RECRUITING

Outcomes

Primary Outcomes

Rebleeding rate at the second look endoscopy

Time frame: 2 year

Central Contacts

Su Jin Hong, MD, PhD

CONTACT

+82-32-621-5087 sjhong@schmc.ac.kr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.